Back to Search Start Over

Melflufen in patients (pts) with relapsed/refractory multiple myeloma (RRMM) refractory to daratumumab (dara) and/or pomalidomide (pom) (OP-106)

Authors :
Richardson, PG
Oriol, A
Larocca, A
Otero, PR
Moreb, J
Blade, J
Hassoun, H
Cavo, M
Alegre, A
Mazumder, A
Maisel, C
Paner, A
Leleu, X
Zonder, JA
Harmenberg, J
Thuresson, S
Zubair, H
Mateos, MV
Source :
Cancer Research, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Publication Year :
2019
Publisher :
American Association for Cancer Research, 2019.

Details

ISSN :
00085472
Database :
OpenAIRE
Journal :
Cancer Research, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Accession number :
edsair.RECOLECTA.....6c14d13ce6bc2972e901689988ce9644

Tools

Authors Abstract Subjects Details